Search clinical trials for: GQ1001

Total 405 results

GeneQuantum Healthcare (Suzhou) Co., Ltd.

Recruiting

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

HER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid Tumor

China, Australia, United States
GemVax & Kael

Recruiting

GV1001 Subcutaneous(SC) for the Treatment of Progressive Supranuclear Palsy (PSP)

Progressive Supranuclear Palsy

Korea, Republic of
GemVax & Kael

Active, not recruiting

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

Mild to Moderate Alzheimer's Disease

Spain, United States, Netherlands, Poland
GemVax & Kael

Recruiting

Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011

Progressive Supranuclear Palsy

Korea, Republic of
Pharmexa A/S

Completed

A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.

Carcinoma, Hepatocellular

France, Germany, Spain
GemVax & Kael

Withdrawn

GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)

Moderate Alzheimer's Disease
GeneQuantum Healthcare (Suzhou) Co., Ltd.

Recruiting

A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors

HER2 Expressing or Mutated Advanced Malignant Solid Tumors

China
GemVax & Kael

Completed

Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients

Alzheimer Disease

Korea, Republic of
Ore Pharmaceuticals, Inc.

Unknown

Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis

Mild to Moderate Ulcerative Colitis

Canada, India
Samsung Pharmaceutical Co., Ltd.

Not yet recruiting

GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)

Moderate to Severe Alzheimer's Disease
GemVax & Kael

Completed

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Oslo University Hospital

Completed

Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma

Malignant Melanoma

Norway
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Active, not recruiting

Study of Efficacy and Safety of GR1501 in Patients With Radiographic Axial Spondyloarthritis

Axial Spondyloarthritis

China
Kael-GemVax Co., Ltd.
Quintiles, Inc.

Unknown

Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer (LucaVax)

Inoperable Stage III Non-small Cell Lung Cancer
Pyramid Biosciences

Not yet recruiting

A Phase 1/2 Study of PBI-410 in Advanced Solid Tumors

Solid Tumor

United States
Livzon Pharmaceutical Group Inc.
Palm Beach CRO; Keystone Bioanalytical, Inc.

Completed

Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US

Solid Tumor Refractory to Standard Therapy

United States
AriBio Co., Ltd.

Recruiting

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

Alzheimer Disease

Korea, Republic of, United States, United Kingdom
AriBio Co., Ltd.

Completed

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

Mild to Moderate Alzheimer's Disease

United States
Renovo

Completed

Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects

Cicatrix

United Kingdom
Equillium
Biocon Limited

Recruiting

A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD (EQUATE)

GVHD | GVHD, Acute | aGVHD | Acute-graft-versus-host Disease

United States
Quantum Genomics SA

Completed

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension (2QG1)

Essential Hypertension

France
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
CStone Pharmaceuticals

Recruiting

A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
Quantum Genomics SA

Terminated

QUantum Genomics Incremental Dosing in Heart Failure - QUID-HF (QUID-HF)

Heart Failure

France, Germany, Netherlands, United Kingdom, Hungary, Norway, Czechia, Poland
Otsuka Novel Products GmbH

Terminated

A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer

Breast Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Salivary Gland Cancer | Squamous Cell Carcinoma of the Cervix

United Kingdom
Equillium
Biocon Limited

Recruiting

A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)

Graft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHD

United States, Korea, Republic of, Germany, Israel, Spain, Belgium, Italy, Australia, France, Canada, Portugal, New Zealand
Equillium
Biocon Limited

Withdrawn

A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19 (EQUINOX)

Coronavirus

Colombia
Equillium
Biocon Limited; Equillium AUS Pty Ltd

Completed

A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma (EQUIP)

Asthma

New Zealand, Australia
Lexeo Therapeutics

Recruiting

Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease (LEADLTFU)

Alzheimer Disease

United States
Fudan University
GeneQuantum Healthcare (Suzhou) Co., Ltd.

Recruiting

GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer

Advanced/ Metastatic Her-2 Positive Breast Cancer

China
Kuhnil Pharmaceutical Co., Ltd.
Neurim Pharmaceuticals Ltd.

Completed

Efficacy and Safety of KI1001 in ≥ 55 Years Old Insomnia Patients

Sleep Initiation and Maintenance Disorders

Korea, Republic of
Lexeo Therapeutics
Weill Medical College of Cornell University; Alzheimer's Drug Discovery Foundation

Active, not recruiting

Gene Therapy for APOE4 Homozygote of Alzheimer's Disease

Alzheimer Disease | Early Onset Alzheimer Disease

United States
TheraVasc Inc.

Completed

Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC

Peripheral Arterial Disease

United States
Amicus Therapeutics

Approved for marketing

Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease

Fabry Disease

United States, Australia
University of Colorado, Boulder
TheraVasc Inc.

Completed

Sodium Nitrite to Treat Arterial Aging

Vascular Aging

United States
Ferrer Internacional S.A.

Completed

Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions

Secondarily Infected Traumatic Lesions

Germany
GeneCradle Inc

Recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients

SMA II

China
Renovo

Completed

Juvista in Scar Revision Surgery of Disfiguring Scars (Revise)

Cicatrix

Spain, France, Hungary, Italy, United Kingdom, United States, Denmark, Germany, Latvia, Poland
Massachusetts General Hospital

Recruiting

AT1001 for the Treatment of COVID-19 Related MIS-C

Covid19 | Multisystem Inflammatory Syndrome in Children

United States
CStone Pharmaceuticals

Completed

A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors

Advanced Cancer

China
CStone Pharmaceuticals
Bayer

Completed

A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors

Advanced Refractory Solid Tumors

Australia
Medexus Pharma, Inc.

Terminated

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

Hemophilia B

United States, United Kingdom, India
Grit Biotechnology

Recruiting

GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors

Adult

China
GeneCradle Inc

Recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients

Spinal Muscular Atrophy

China
Equillium
Equillium AUS Pty Ltd

Active, not recruiting

Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata

Alopecia | Alopecia Areata | Alopecia Totalis | Alopecia Universalis

Australia, New Zealand
GeneCradle Inc

Recruiting

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients

Spinal Muscular Atrophy Type 3

China
Grit Biotechnology

Recruiting

GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Solid Tumors, Adult

China
Quantum Genomics SA
PRA Health Sciences

Terminated

Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) (REFRESH)

Hypertension (HTN)

United States, Canada
Norfolk and Norwich University Hospitals NHS Foundation...
GreenCross Medico Limited

Not yet recruiting

Heat Therapy for Peripheral Arterial Disease (HEATPAD) (HEATPAD)

Peripheral Arterial Disease | Intermittent Claudication | Critical Limb Ischemia
Graviton Bioscience Corporation

Completed

Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects

Phase 1

United States
CStone Pharmaceuticals

Completed

A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL)

Extranodal Natural Killer/T-Cell Lymphoma

United States, China

Search clinical trials for: GQ1001

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations